Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study

HPB (Oxford). 2017 Feb;19(2):108-117. doi: 10.1016/j.hpb.2016.11.005. Epub 2016 Dec 9.

Abstract

Background: Estimation of the future liver remnant function (eFLRF) can avoid post-hepatectomy liver failure (PHLF). In a previous study, a cutoff value of 2.3%/min/m2 for eFLRF was a better predictor of PHLF than future liver remnant volume (FLRV%). In this prospective interventional study, investigating a management strategy aimed at avoiding PHLF, this cutoff value was the sole criterion assessing eligibility for hepatectomy, with or without portal vein occlusion (PVO).

Methods: In 100 consecutive patients, eFLRF was determined using the formula: eFLRF = FLRV% × total liver function (TLF). Group 1 (eFLRF >2.3%/min/m2) underwent hepatectomy without preoperative intervention. Group 2 (eFLRF <2.3%/min/m2) underwent PVO and re-evaluation of eFLRF at 4-6 weeks. Hepatectomy was performed if eFLRF had increased to >2.3%/min/m2, but was considered contraindicated if the value remained lower.

Results: In group 1 (n = 93), 1 patient developed grade B PHLF. In group 2 (n = 7) no PHLF was recorded. Postoperative recovery of TLF in patients with preoperative eFLRF <2.3%/min/m2 occurred more rapidly when PVO had been performed.

Conclusion: A predefined cutoff for preoperatively calculated eFLRF can be used as a tool for selecting patients prior to hepatectomy, with or without PVO, thus avoiding PHLF and PHLF-related mortality.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Decision Support Techniques*
  • Embolization, Therapeutic / adverse effects
  • Embolization, Therapeutic / methods*
  • Female
  • Hepatectomy / adverse effects*
  • Humans
  • Liver / pathology
  • Liver / physiopathology
  • Liver / surgery*
  • Liver Failure / etiology
  • Liver Failure / prevention & control*
  • Liver Function Tests*
  • Male
  • Middle Aged
  • Organ Size
  • Patient Selection
  • Portal Vein*
  • Predictive Value of Tests
  • Prospective Studies
  • Recovery of Function
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome